Wilson Sonsini Goodrich & Rosati advised Terray Therapeutics on the deal. Terray Therapeutics, an AI-powered drug discovery company, announced the closing of a $60 million Series...
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here